EGFR-IN-23 is a potent inhibitor of the epidermal growth factor receptor (EGFR) tyrosine kinase, exhibiting an IC50 of 8.05 nM in BaF3 cells expressing the EGFR-DEL19/T790M/C797S mutation. This compound demonstrates significant effectiveness in inhibiting cell proliferation associated with oncogenic EGFR signaling. EGFR-IN-23 is suitable for research applications focused on cancer biology, particularly in studies investigating resistance mechanisms in targeted therapies.
EGFR-IN-23 is a potent inhibitor of the epidermal growth factor receptor (EGFR) tyrosine kinase, exhibiting an IC50 of 8.05 nM in BaF3 cells expressing the EGFR-DEL19/T790M/C797S mutation. This compound demonstrates significant effectiveness in inhibiting cell proliferation associated with oncogenic EGFR signaling. EGFR-IN-23 is suitable for research applications focused on cancer biology, particularly in studies investigating resistance mechanisms in targeted therapies.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula: